MedTrace Logo

What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?

NCT03815357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 380

Last updated 2022-07-06

No results posted yet for this study

Summary

This is a multicentre prospective audit to determine the incidence of immunodeficiency in children with IPD.

Aims and/or research question of the project

1. To determine the incidence of primary immunodeficiency in children \>2 years who present with IPD
2. To determine the types of immunodeficiency associated with IPD in children

Conditions

  • Invasive Pneumococcal Disease, Recurrent Isolated, 1
  • Invasive Pneumococcal Disease, Recurrent Isolated, 2
  • Invasive Pneumococcal Disease, Protection Against
  • Primary Immunodeficiency

Interventions

OTHER

Referral to Immunology

Screening for primary immunodeficiency including splenic dysfunction

Sponsors & Collaborators

  • Royal Children's Hospital

    collaborator OTHER

  • Murdoch Childrens Research Institute

    lead OTHER

Eligibility

Min Age
0 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Australia
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03815357 on ClinicalTrials.gov